 |
|
|
| |
Extended Treatment of HBeAg+ CHB Subjects with the Capsid Assembly Modulator ALG-000184 with or without Entecavir is Associated with Reductions in Viral Markers and Favorable Anti-HBeAg trends
|
| |
| |
EASL 2024 June 5-8 Milan Italy
Man-Fung Yuen1, Edward Gane2, Kosh Agarwal3, Junqi Niu4, Hong Ren5, Yanhua Ding4, Xieer Liang6, Xian Yu5, Jia Xu4, Alina Jucov7, Alexei Haceatrean7, Min Wu8,
Kha Le8, Maida Maderazo8, Lawrence M. Blatt8, Sushmita Chanda8, Tse-I Lin8, Matthew McClure8 and Jinlin Hou6
|
| |
|
|
|
|
|
